Free Trial

Van Lanschot Kempen Investment Management N.V. Has $70.66 Million Stock Holdings in Healthpeak Properties, Inc. $DOC

Healthpeak Properties logo with Finance background

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Van Lanschot Kempen Investment Management N.V. decreased its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 23.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,494,724 shares of the real estate investment trust's stock after selling 1,052,451 shares during the quarter. Healthpeak Properties makes up approximately 0.7% of Van Lanschot Kempen Investment Management N.V.'s portfolio, making the stock its 28th largest holding. Van Lanschot Kempen Investment Management N.V. owned 0.50% of Healthpeak Properties worth $70,663,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. Hsbc Holdings PLC raised its position in shares of Healthpeak Properties by 5.1% in the first quarter. Hsbc Holdings PLC now owns 2,290,430 shares of the real estate investment trust's stock valued at $46,253,000 after purchasing an additional 111,142 shares during the period. Fuller & Thaler Asset Management Inc. raised its position in shares of Healthpeak Properties by 6.5% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 18,397,841 shares of the real estate investment trust's stock valued at $372,004,000 after purchasing an additional 1,129,924 shares during the period. Brooklyn Investment Group raised its position in shares of Healthpeak Properties by 198.9% in the first quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 873 shares during the period. Raymond James Financial Inc. raised its position in shares of Healthpeak Properties by 14.4% in the first quarter. Raymond James Financial Inc. now owns 1,271,968 shares of the real estate investment trust's stock valued at $25,719,000 after purchasing an additional 159,724 shares during the period. Finally, Tocqueville Asset Management L.P. raised its position in shares of Healthpeak Properties by 23.0% in the first quarter. Tocqueville Asset Management L.P. now owns 226,482 shares of the real estate investment trust's stock valued at $4,579,000 after purchasing an additional 42,277 shares during the period. Institutional investors own 93.57% of the company's stock.

Insiders Place Their Bets

In other Healthpeak Properties news, CEO Scott M. Brinker purchased 1,490 shares of the firm's stock in a transaction on Monday, August 4th. The shares were purchased at an average price of $16.83 per share, for a total transaction of $25,076.70. Following the completion of the purchase, the chief executive officer directly owned 211,906 shares of the company's stock, valued at approximately $3,566,377.98. This represents a 0.71% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Tommy G. Thompson bought 5,777 shares of Healthpeak Properties stock in a transaction dated Wednesday, May 28th. The stock was purchased at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the purchase, the director directly owned 144,290 shares in the company, valued at $2,491,888.30. This represents a 4.17% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 14,560 shares of company stock worth $249,898 in the last quarter. Corporate insiders own 0.23% of the company's stock.

Healthpeak Properties Stock Performance

DOC traded up $0.4450 during trading on Friday, reaching $17.7250. 8,696,799 shares of the company's stock were exchanged, compared to its average volume of 8,563,543. Healthpeak Properties, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $23.26. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.06. The business has a 50 day moving average price of $17.62 and a 200 day moving average price of $18.38. The company has a market capitalization of $12.32 billion, a P/E ratio of 73.86, a PEG ratio of 2.20 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The firm had revenue of $694.35 million for the quarter, compared to the consensus estimate of $697.14 million. During the same quarter in the previous year, the company earned $0.45 earnings per share. The business's revenue was down .2% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The firm also recently declared a dividend, which will be paid on Friday, August 29th. Shareholders of record on Tuesday, August 19th will be paid a dividend of $0.1017 per share. The ex-dividend date is Monday, August 18th. This represents a yield of 705.0%. Healthpeak Properties's payout ratio is currently 508.33%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on DOC shares. Wells Fargo & Company dropped their price target on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating on the stock in a research report on Monday, June 2nd. Morgan Stanley dropped their target price on shares of Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating on the stock in a research report on Friday. Wedbush dropped their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Evercore ISI dropped their price objective on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Finally, Robert W. Baird set a $21.00 price objective on shares of Healthpeak Properties and gave the stock an "outperform" rating in a report on Wednesday, July 30th. Seven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $21.70.

View Our Latest Stock Report on Healthpeak Properties

Healthpeak Properties Company Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Further Reading

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines